Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain and Impairment of Glucose Tolerance in Mice via Effects on the Hepatic Hormone FGF21

被引:19
作者
Tian, Lili [1 ,2 ,3 ]
Ning, Hongmei [1 ,4 ]
Shao, Weijuan [1 ,2 ,3 ]
Song, Zhuolun [1 ,2 ,3 ]
Badakhshi, Yasaman [1 ,2 ,3 ]
Ling, Wenhua [5 ]
Yang, Burton B. [6 ]
Brubaker, Patricia L. [2 ,7 ]
Jin, Tianru [1 ,2 ,3 ,7 ]
机构
[1] Univ Hlth Network, Res Inst, Div Adv Diagnost, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Banting & Best Diabet Ctr, Toronto, ON, Canada
[4] Henan Inst Sci & Technol, Xinxiang, Henan, Peoples R China
[5] Sun Yet Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou, Peoples R China
[6] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
anthocyanin; Cy3G; dietary intervention; FGF21; GLP-1; OGTT; GLUCAGON-LIKE PEPTIDE-1; PROGLUCAGON GENE-TRANSCRIPTION; INSULIN-RESISTANCE; PPAR-ALPHA; CURCUMIN; INFLAMMATION; ANTHOCYANIN; ACTIVATION; SECRETION; EXTRACT;
D O I
10.1093/jn/nxaa140
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Dietary polyphenols including anthocyanins target multiple organs. Objective: We aimed to assess the involvement of glucagon-like peptide 1 (GLP-1), leptin, insulin and fibroblast growth factor 21 (FGF21) in mediating metabolic beneficial effects of purified anthocyanin cyanidin-3-glucoside (Cy3G). Methods: Intestinal proglucagon gene (Gcg; encoding GLP-1) and liver Fgf21 expression were assessed in 6-wk-old male C57BL-6J mice fed a low-fat-diet (LFD; 10% of energy from fat), alone or with 1.6 mg Cy3G/L in drinking water for 3 wk [experiment (Exp.) 1; n = 5/group]. Similar mice were fed the LFD or a high-fat diet (HFD; 60% energy from fat) with or without Cy3G for 20 wk. Half of the mice administered Cy3G also received 4 broad-spectrum antibiotics (ABs) in drinking water between weeks 11 and 14, for a total of 6 groups (n = 8/group). Metabolic tolerance tests were conducted between weeks 2 and 16. Relevant hormone gene expression and plasma hormone concentrations were assessed mainly at the end of 20 wk (Exp. 2). Results: In Exp. 1, Cy3G administration increased ileal but not colonic Gcg level by 2-fold (P < 0.05). In Exp. 2, Cy3G attenuated HFD-induced body-weight gain (20.3% at week 16), and improved glucose tolerance (26.5% at week 15) but not insulin tolerance. Although Cy3G had no effect on glucose tolerance in LFD mice, LFD/Cy3G/AB mice showed better glucose tolerance than LFD/Cy3G mice (23%). In contrast, HFD/Cy3G/AB mice showed worse glucose tolerance compared with HFD/Cy3G mice (15%). Beneficial effects of Cy3G in HFD mice were not associated with changes in plasma leptin, insulin or GLP-1 concentrations. However, Cy3G increased hepatic Fgf21 expression in mice in Exp. 1 by 4-fold and attenuated Fgf21 overexpression in HFD mice (Exp. 2, 22%), associated with increased expression of genes that encode FGFR1 and beta-klotho (>3-fold, P < 0.05). Conclusions: Dietary Cy3G may reduce body weight and exert metabolic homeostatic effects in mice via changes in hepatic FGF21.
引用
收藏
页码:2101 / 2111
页数:11
相关论文
共 54 条
  • [1] Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice
    Anhe, Fernando F.
    Varin, Thibault V.
    Le Barz, Melanie
    Pilon, Genevieve
    Dudonne, Stephanie
    Trottier, Jocelyn
    St-Pierre, Philippe
    Harris, Cory S.
    Lucas, Michel
    Lemire, Melanie
    Dewailly, Eric
    Barbier, Olivier
    Desjardins, Yves
    Roy, Denis
    Marette, Andre
    [J]. DIABETOLOGIA, 2018, 61 (04) : 919 - 931
  • [2] A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss
    Anhe, Fernando F.
    Nachbar, Renato T.
    Varin, Thibault V.
    Vilela, Vanessa
    Dudonne, Stephanie
    Pilon, Genevieve
    Fournier, Maryse
    Lecours, Marc-Andre
    Desjardins, Yves
    Roy, Denis
    Levy, Emile
    Marette, Andre
    [J]. MOLECULAR METABOLISM, 2017, 6 (12): : 1563 - 1573
  • [3] Role of leptin in the regulation of glucagon-like peptide-1 secretion
    Anini, Y
    Brubaker, PL
    [J]. DIABETES, 2003, 52 (02) : 252 - 259
  • [4] Microbial regulation of the L cell transcriptome
    Arora, Tulika
    Akrami, Rozita
    Pais, Ramona
    Bergqvist, Linda
    Johansson, Bengt R.
    Schwartz, Thue W.
    Reimann, Frank
    Gribble, Fiona M.
    Backhed, Fredrik
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [5] Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
  • [6] Activation of cAMP Signaling Attenuates Impaired Hepatic Glucose Disposal in Aged Male p21-Activated Protein Kinase-1 Knockout Mice
    Chiang, Yu-ting Alex
    Ip, Wilfred
    Shao, Weijuan
    Song, Zhuolun Eric
    Chernoff, Jonathan
    Jin, Tianru
    [J]. ENDOCRINOLOGY, 2014, 155 (06) : 2122 - 2132
  • [7] Curcumin supplementation mitigates NASH development and progression in female Wistar rats
    Cunningham, Rory P.
    Moore, Mary P.
    Moore, Angelique N.
    Healy, James C.
    Roberts, Michael D.
    Rector, R. Scott
    Martin, Jeffrey S.
    [J]. PHYSIOLOGICAL REPORTS, 2018, 6 (14):
  • [8] ACTIVATION OF PROGLUCAGON GENE-TRANSCRIPTION BY PROTEIN KINASE-A IN A NOVEL MOUSE ENTEROENDOCRINE CELL-LINE
    DRUCKER, DJ
    JIN, TR
    ASA, SL
    YOUNG, TA
    BRUBAKER, PL
    [J]. MOLECULAR ENDOCRINOLOGY, 1994, 8 (12) : 1646 - 1655
  • [9] Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice
    Ejaz, Asma
    Martinez-Guino, Laura
    Goldfine, Allison B.
    Ribas-Aulinas, Francesc
    De Nigris, Valeria
    Ribo, Silvia
    Gonzalez-Franquesa, Alba
    Garcia-Roves, Pablo M.
    Li, Elizabeth
    Dreyfuss, Jonathan M.
    Gall, Walt
    Kim, Jason K.
    Bottiglieri, Teodoro
    Villarroya, Francesc
    Gerszten, Robert E.
    Patti, Mary-Elizabeth
    Lerin, Carles
    [J]. DIABETES, 2016, 65 (04) : 902 - 912
  • [10] Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial
    Ferguson, Jessica J. A.
    Stojanovski, Elizabeth
    MacDonald-Wicks, Lesley
    Garg, Manohar L.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 82 : 22 - 33